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Abstract
Epithelial sodium channels (ENaC) are localized at the apical membrane of the epithelium, and are
responsible for salt and fluid reabsorption. Renal ENaC takes up salt, thereby controlling salt content in
serum. Loss-of-function ENaC mutations lead to low blood pressure due to salt-wasting, while
gain-of-function mutations cause impaired sodium excretion and subsequent hypertension as well as
hypokalemia. ENaC activity is regulated by intracellular and extracellular signals, including hormones,
neurotransmitters, protein kinases, and small compounds. Cyclic nucleotides are broadly involved in
stimulating protein kinase A and protein kinase G signaling pathways, and, surprisingly, also appear to
have a role in regulating ENaC. Increasing evidence suggests that the cGMP analog, CPT-cGMP,
activates αβγ-ENaC activity reversibly through an extracellular pathway in a dose-dependent manner.
Furthermore, the parachlorophenylthio moiety and ribose 2’-hydroxy group of CPT-cGMP are
essential for facilitating the opening of ENaC channels by this compound. Serving as an extracellular
ligand, CPT-cGMP eliminates sodium self-inhibition, which is a novel mechanism for stimulating salt
reabsorption in parallel to the traditional NO/cGMP/PKG signal pathway. In conclusion, ENaC may be
a druggable target for CPT-cGMP, leading to treatments for kidney malfunctions in salt reabsorption.
Key words: amiloride-sensitive sodium channel; cyclic guanosine nucleotides; molecular docking; lung edema.

Introduction
Cyclic guanosine monophosphates (cGMP) are
important cyclic nucleotides, playing a critical role in
signal transduction in many different organisms1.
Signal transduction in eukaryotic cells is essential for
moderating the transmission of information through
the cell membrane, and as a second messenger, cGMP
regulates numerous essential processes in cells by
amplifying external signals, for example, from hormones and neurotransmitters. Cytosolic cGMP binds
to cyclic nucleotide-gated ion channels1, 2 and phosphorylates protein kinase G (PKG) directly3-5.
Amiloride-sensitive epithelial sodium channels
(ENaC) behave as ligand-gated channels, similar to
several other members of the ENaC/degenerin family6. In the late part of the renal distal convoluted

tubule, sodium is predominately reabsorbed via the
electrogenic amiloride-sensitive ENaC. In the
connecting tube, and the collecting duct, ENaC is the
only pathway for retaining salt, and ENaC controls
renal sodium excretion and provides the driving force
for potassium secretion through the renal outer
medullary potassium channel7. Loss-of-function
ENaC genetic variants lead to low blood pressure,
while gain-of-function mutants have been identified
in Liddle’s syndrome, which is characterized by
increased ENaC abundance, augmented opening
time, and consequent salt retention, and eventually
volume-expended hypertension8. An autosomal
recessive form of pseudohypoaldosteronism type 1 is
caused by mutations in ENaC, with usually severe
http://www.ijbs.com
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and persisting multiorgan symptoms 9.
Five ENaC subunits have been cloned to date,
namely α-, β-, γ-, δ-, and ε-ENaC. Among them, the βand γ-subunits regulate the channel activity of the
‘self-conducting’ α-, δ-, and ε-ENaC subunits when
heterologously expressed in oocytes and cell lines 10-12.
Luminal impermeable reagents and hormones have
been confirmed to regulate ENaC in lung, kidney, and
colon, and ENaC is regulated by a spectrum of protein
kinases, such as PKG and protein kinase A (PKA) 13-15.
However, our understanding of the cellular and
molecular mechanisms by which cGMP regulates
ENaC is incomplete.

Regulation of Epithelial Sodium Channels by CPT-cGMP
Cyclic GMP is one of the most prominent nucleotides in eukaryotic cells. Guanylyl cyclases elevate
cell cGMP levels, which regulate complex signaling
cascades through immediate downstream effectors,
cGMP-dependent protein kinases, and cyclic nucleotide-gated ion channels 1. CPT-cGMP is a derivative
analog of parental cGMP, and has long been used for
studying the NO/cGMP/PKG cascade 16, 17.
Regulation of epithelial sodium channels by
CPT-cGMP and its cAMP analog is summarized in
Table 1. Species- and culture-dependence of ENaC
properties, and the strategies used for elevating cell
cGMP content, including nitric oxide (NO) donors
and PKG isoform-specific cGMP analogs, may
contribute to these divergent observations.

Cyclic GMP/PKGII pathway
To date, three PKG isoforms have been isolated,
namely, PKGI-α, PKGI-β, and PKGII 18. Accumulating
evidence from genetically engineered animals
suggests that cardiovascular phenotypes are

predominant with the PKGI knockout, while PKGII
deficiency leads to dysfunction in epithelial tissues
[19, 20]. Our results using Ussing chamber and
voltage clamp techniques showed that 8-pCPT-cGMP
increased the amiloride-sensitive short-circuit current
across H441 cell monolayers and also increased
heterologously expressed αβγδ-ENaC activity in a
dose-dependent manner, most probably through the
stimulation of PKGII enzymatic activity and
subsequent activation of channel function 15 (Figure
1). A carton briefly showed the interaction of cGMP
and ENaC (Figure 2). Recent studies showed that
PKG-interacting proteins mediate cellular targeting of
PKG isoforms by interacting with their leucine zipper
domains, and that protein recognition is mediated
through surface charge interactions 19.

Extracellular ligand pathway
In sharp contrast to the native ENaC,
heterologously expressed αβγ-ENaC in oocytes has
been considered to be cAMP/PKA-independent,
particularly for acute regulation. The cell-permeable
PKGII isoform-specific activator, 8-pCPT-cGMP,
acutely stimulates human, rat, and mouse αβγ-ENaC
reversibly. Furthermore, intraoocyte domains of
ENaC subunits and traditional soluble protein kinases
may not be targets of this compound 20. A critical
extracellular domain has recently been identified as
the 8-CPT-cAMP binding site 21, indicating that
8-CPT-cAMP is an extracellular ligand for ENaC 6, 21.
Moreover, 8-CPT-cAMP can stimulate δβγ-ENaC up
to approximately 3-fold, and αβγ-ENaC by 2-fold 14.
Co-expression of δ-ENaC with αβγ channels
conferred CPT-cAMP-mediated activation with an
EC50 (concentration for 50% of maximal effect) value
of 30 μM, similar to that for αβγ channels (49 μM) 22.

Table 1. Regulation of sodium channel activity by nucleotides.
Nucleotides
CPT-cGMP*

CPT-cAMP

Concentration
1 μM
400 μM
2 mM
100 μM
4 mM
10 μM
0.1 - 1000 μM
0.5 mM
0.2 mM
1 mM
100 μM
100 μM
40 μM
200 μM
100 µM

Models
Xenopus 2F3 cells
Rat ATII cells
Rat bronchioalveolar epithelial cells
Rat ATII cells
Human A549 cells
Frog urinary bladder epithelium
Heterologous human αβγ ENaC in oocytes
Human lung lobes
Mouse pleural tissues
Rat ATII cells
Human A549 cells
MDCK cells
Liddle's disease lymphocytes
Heterologous human αβγ ENaC in oocytes
BeWo cells

Effects
Increase in Isc
No change in Isc
Increase in Isc/ 22Na influx
Increase in whole cell activity
Increase in whole cell activity
Increase in single channel activity
Increase in whole cell activity
Increase in alveolar fluid clearance
Increase in Isc
Decrease in single channel activity
Decrease in whole cell activity
Increase in Isc
Increase in whole cell activity
Increase in whole cell activity
Increase in whole cell activity

Ref.
62
63
64, 65
66
67
68, 69
16
24
15
56
70

71
14, 21, 72
73

*Abbreviations: ATII, alveolar type II epithelial; MDCK, Madin-Darby canine kidney; Isc, short-circuit current; CPT-cAMP, 8-pCPT-cAMP-Na; CPT-cGMP,
8-pCPT-cGMP-Na.
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Relieving external sodium self-inhibition

Figure 1. Stimulation of heterologously expressed human ENaCs in Xenopus
oocytes by cGMP. A: Representative current trace recorded at +40 mV and
−100 mV. Oocytes were perfused with 8-pCPT-cGMP ranging from 1 μM to 1
mM, as indicated by arrows. Amiloride was added to the bath before the
recordings were terminated. B: Dose-response curve. The average
cGMP-activated current fraction in the presence of cGMP (ΔI) was normalized
to the maximal cGMP-elevated current (ΔImax) and plotted as a function of
cGMP concentration. Dashed lines and the EC50 value were derived by fitting
the raw data with the Hill equation. n=9. C: Average amiloride-sensitive (AS)
αβγδ ENaC currents before (control) and after cGMP perfusion. Holding
potential, −100 mV. n=10. Figure reprinted from 15, and used with permission.

External sodium self-inhibition is an intrinsic
feature of ENaC. A rapidly increase in extracellular
sodium ions to a physiological concentration (150 mM
for mammals and 100mM for amphibians) generates a
maximal peak current in seconds, and then the permeability of ENaC to Na+ ions is gradually reduced to
a relatively stable level with a current level of approximately half of the maximal value. This phenomenon is called extracellular sodium self-inhibition
of ENaC activity. It differs from the down-regulation
of ENaC activity by slowly accumulating intracellular
Na+ content in a feedback manner. External Na+
self-inhibition is a crucial mechanism to limit overwhelming salt absorption to prevent a quick raise in
epithelial cell volume and blood pressure. It maintains salt and fluid homeostasis at the luminal surface
of the respiratory system to keep normal cilia beating
in the airways, hyperpolarize apical membrane, and
finely adjust fluid volume to host leukocytes and
physiological regulators as the forefront battle against
noxious aspirated insults 22.
Our previous studies showed that external
CPT-cAMP stimulated human, but not rat and
murine, αβγ-ENaC in a dose-dependent and external
sodium concentration-dependent fashion 14. ENaC
mutations that abolished self-inhibition (βΔV348 and
γH233R) almost completely eliminated CPT-cAMP
mediated activation. In contrast, mutations that both
enhanced self-inhibition and elevated CPT-cAMP
sensitivity increased the stimulating effects of the
compound. Our above data confirmed that
CPT-cAMP acts as a ligand to regulate heterologous
ENaC by relieving self-inhibition. Edelheit et al 23
studied alanine mutations in 17 conserved charged
residues of ENaC and found that these residues are
involved in conformational changes that lead to
channel constriction and to the sodium self-inhibition
response upon sodium ion flooding. Similarly, our
recent data showed that elimination of self-inhibition
of αβγ-ENaC may be a novel mechanism for
CPT-cGMP to stimulate salt reabsorption in the
human epithelium (Figure 3) 24.

Moiety specificity for CPT-cGMP serving
as an ENaC ligand

Figure 2. Extracellular and intracellular mechanisms for CPT-cGMP or
CPT-cAMP to activate ENaC. These cell permeable compounds, when applied
in vivo or in vitro, will stimulates ENaC activity by both acting as an external
ligand to release self-inhibition and as a cytosolic signal molecule to phosphorylate cGKII that subsequently activates ENaC.

CPT-cGMP, an analog of CPT-cAMP, was
capable of activating ENaC in the identical manner in
cell-free outside-out patches 16. Both point mutations
of the putative consensus PKG phosphorylation sites
and truncation of entire cytosolic NH2- and
COOH-terminal tails of ENaC did not alter the
response to CPT-cGMP. The ENaC activity was
activated to the same extent by CPT-cGMP in cells in
http://www.ijbs.com
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which PKGII expression was knocked down using
small interfering RNA. As we demonstrated, the
parachlorophenylthio moiety and ribose 2’-hydroxy
group of CPT-cGMP are crucial for activating ENaC
16, and CPT-cGMP may serve as a novel ENaC ligand
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in addition to activating the PKG signal. The strict
requirement for both parachlorophenylthio and the
ribose 2’-hydroxy groups helps to clarify the basis for
the inconsistent results observed with the regulation
of ENaC by a variety of cGMP analogs (Figure 4).

Figure 3. CPT-cGMP modifies self-inhibition of αβγ ENaC in oocytes. Self-inhibition was initiated by fast switching the low sodium bath solution (1 mM sodium) to
regular ND96 medium (96 mM sodium). A: Whole-cell current trace digitized at -60 mV. CPT-cGMP (0.2 mM) was added after the first three sweeps and washed out
for the last three sweeps. B: Normalized and averaged currents; *P < 0.05 and **P < 0.01 versus the first sweep. C: Comparison of CPT-cGMP on self-inhibition of
αβγ and δβγ ENaC channels. Paired traces were recorded before and after application of CPT-cGMP, n=9. Figure reprinted from 24, and used with permission.

Figure 4. Domain-dependence of CPT-cGMP and CPT-cAMP analogs. A:
Modified positions are shown for 8-pCPT-cGMP and 8-CPT-cAMP. B: The
responses of human αβγ-ENaC to these compounds (0.2 mM) were compared:
8-pCPTcGMP, (CPT-cGMP); 8-CPT-cAMP, (CPT-cAMP); 2-aminophenylthiocGMP, (APT-cGMP); 8-pCPT-methylated ribose 2’-hydroxy (2’-O-Me)-cGMP
(CPT-2’OMe-cGMP); Sp-8-Br-cGMP, (Br-cGMP); 8-CPT-2’-O-Me-cAMP,
(CPT-2’OMe-cAMP), 4-chlorothiolphenol, (CPT); a mixture of CPT and KOH,
(CPT+OH). The normalized currents before and after application of these
compounds were compared with that of the standard cGMP molecule (Std
cGMP). **P < 0.01, *P < 0.05. Numbers in parentheses are the number of
oocytes examined for each group. Figure reprinted from 16, and used with
permission.

CPT-cGMP ligand docking to ENaC
In our previous experiment, we constructed
mutants abolishing (βV348 and γH233R), or
augmenting
(αY458A
and
γM432G),
ENaC
14,
24
self-inhibition
. The mutations eliminating
self-inhibition resulted in a loss of response to
CPT-cGMP, whereas those enhancing self-inhibition
facilitated the stimulatory effects of this compound.
Figure 5 shows the potential binding sites for the
CPT-cGMP ligand in ENaC domains that are crucial
for self-inhibition. βV348 is located in the center of the
palm region of the subunit, and γH233 is located in the
vicinity of the putative binding site for protons. These
domains potentially directly or allosterically interact
with CPT-cGMP.
http://www.ijbs.com
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Specific domains/sites
changing self-inhibition

His(88) and Asp(516) of the
γ subunit play a role in the
sodium
Zn2+-regulating
self-inhibition mentioned above.
Recent studies showed that
palmitoylation of the γ subunit
activates ENaC by increasing
the open probability of the
channels 40. ENaC mutants with
the mutations γC33A, γC41A, or
γC33A/C41A have significantly
enhanced sodium self-inhibition
and reduced open probability
compared with wild type
Figure 5. Homology model of trimeric human αβγ ENaC. The subunits are color-coded as follows: α, grey
ENaCs, suggesting that ENaC
(back, center); β, cyan (front, right); γ, red (front, left). A: Side view of the entire trimer. Two dashed grey lines
palmitoylation is an important
indicate the plasma membrane. The locations of the mutations γH233 and βV348 are marked by yellow boxes. B:
Close-up view, showing the location of βV348. Note that βV348 is located in the center of the palm region of the
post-translational mechanism of
subunit, and its downstream residues extend to the wrist region of the subunit that seems to be important in the
channel
regulation. Exon 11
coupling between extracellular domains to the pore region. Thus, deletion of βV348 may change the position and
within the human α, β, and γ
orientation of the downstream residues. γH233 is located in the vicinity of the putative binding site for protons.
Since 8-CPT-cGMP is much larger than a proton, its binding site may include the H233 residue.
ENaC
genes
encodes
structurally homologous yet
functionally diverse domains,
and exon 11 in the α-subunit encodes a module that
Self-Inhibition as a Therapeutic Mecharegulates channel gating 41.
nism
In contrast to the other mutations, γL511Q
largely eliminated the sodium self-inhibition reReagents able to release self-inhibition
sponse, reflecting a down-regulation of ENaC open
Previous results suggested that external Zn2+
probability by extracellular sodium 42. γL511Q is a
rapidly and reversibly activates ENaC in a
gain-of-function human ENaC variant and it enhances
dose-dependent manner by relieving the channel
ENaC activity by increasing channel open probability
from sodium self-inhibition25. In addition to Zn, exand dampens channel regulation by extracellular sotracellular chloride 26, temperature27, 28, halogenated
dium and proteases 42.
gases 27-29, sulfhydryl group-modifying reagents (e.g.,

p-chloromercuriphenylsulfonate,
pCMPS
and
p-chloromercuribenzoate, pCMB) 30, p-chloromercuribenzoate benzimidazolylguanidine 30-33, protons
26, cupper 34, and proteases 28, 35, 36 are also proposed to
modulate ENaC-gating by relieving sodium
self-inhibition. A classic earlier review summarized
most of these reagents27,37,38. Non-cleaved channels
have a low intrinsic open probability that may reflect
enhanced channel inhibition by external sodium, and
cleavage at a minimum of two sites within the α- or
γ-ENaC subunits is required to activate the channel,
presumably by releasing inhibitory fragments 39. The
extent of ENaC proteolysis is dependent on channel
residency time at the plasma membrane, as well as on
the balance between levels of expression of proteases
that activate epithelial sodium channels and inhibitors
of these proteases. For example, furin cleavage of
ENaC subunits activates the channels by relieving
sodium self-inhibition, and this activation requires
that the α-ENaC subunit be cleaved twice35.

Therapeutic effects of targeting self-inhibition
Renal handling of sodium and water is abnormal
in chronic kidney diseases. Filtrated sodium is
reabsorbed from the glomerular filtrate, and
potassium is secreted through a tight epithelium in
the kidney. Sodium crosses the apical membrane and
enters the epithelial cell through the ion-selective
ENaC 43. ENaC is responsible for the reabsorption of
sodium through the apical membrane of the
connecting tubule and the collecting duct, and plays a
key role in controlling sodium balance, extracellular
fluid volume, and blood pressure 44. Regulated
epithelial sodium channel proteolysis has been
observed in rat kidney and in human airway epithelia.
Pseudohypoaldosteronism type 1 is a monogenic
disorder of mineralocorticoid resistance characterized
by salt-wasting, hyperkalemia, high aldosterone levels, and failure to thrive 45. An autosomal recessive
form of pseudohypoaldosteronism type 1 is caused by
mutations in ENaC, and is usually associated with
http://www.ijbs.com
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severe and persisting multiorgan symptoms. The
relief of self-inhibition by CPT-cAMP contributes to
the acute effects, in addition to the well-known
cAMP-PKA signal pathway 14. In fact, the clinical
relevance of the abnormal regulation of ENaC by
CPT-cAMP has been implicated in the upregulation of
ENaC
in
autosomal
recessive
pseudohypoaldosteronism type 1 46.
Another distressed transapical sodium transport
occurs in injured lungs, for example, acute lung injury
(ALI) and acute respiratory distress syndrome
(ARDS) (please see classical reviewes 47-51). Apical
ENaC contributes to up to 60% of transepithelial
sodium transport in mammalian lungs under
physiological conditions. This critical process is
sensitive to aspirated pollutants, allergens, pathogens,
and bacterial endotoxins. In addition to increased
leaking through alveolar microvascular endothelium
(indirect ALI), lung edema ususally results from
reduced edema fluid resolution via ENaC (direct
ALI). ENaC is a promising target for developing new
therapeutical strategies to alleviate lung edema, at
least for the phenotype of direct ALI 52, 53.

CPT-cGMP and self-inhibition
Human serum cGMP level is 6 nM and 3-time
greater in human bronchoalveolar lavage 54. It appears
that cGMP may serve as an autocrine and paracrine to
regulate ENaC function. However, the effective dose
for CPT-cGMP and CPT-cAMP to blunt self-inhibition
is micromolar, suggesting an uncertain physiological
role for cGMP and analogs. A large dose of cGMP
compound (1 mg/kg) was administered to patients as
reported by two clinical trials 55, and numerous preclinical studies (from 100 µM to 2 mM) 56-58. It is
therefore feasible to apply aerosolized nucleotides to
mitigate edematous lung injury. We have demonstrated that CPT-cGMP up-regulates ENaC via two
mechanisms: release self-inhibition externally and
activates ENaC through cGMP/cGKII pathway intracellularly 24. Thus, these compounds could regulate
sodium absorption via either or both mechanisms in a
cell permeability-dependent manner. Administration
of cAMP could be a potent pharmaceutical treatment
for edematous lung injury 59, and cGMP may have
similar potential. cGMP increased in murine and rat
lungs both in vivo and in vitro following NO
application 60, and increased cGMP may augment the
cGMP-sensitive pathway for lung fluid removal from
alveolar sacs 61. Our previous study demonstrated for
the first time that PKGII is an ENaC activator in
non-ciliated bronchial secretory cells 15. Accordingly,
upregulation of the rate-limiting ENaCs in respiratory
epithelial cells by specific PKGII activators may be a
potent clinicopharmaceutical strategy for alleviating
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airspace flooding in fatal edematous lung diseases.
The observation of our previous study that specific
moieties of 8-pCPT-cGMP are required for activating
ENaC may provide pivotal information for
developing potential ENaC channel openers
structurally related to 8-pCPT-cGMP, which would be
extremely useful for treating diseases associated with
lower ENaC function. We postulate that when the
tight epithelial layer is damaged, for example, in injured lungs, even though the mixture of extracellular
matrix proteins, including collagens, albumin, and
fibrins, will seal the epithelial cell-free alveolar surface, the potency of ENaC stimulator will be limited
significantly. Therefore, the integrity of the tight alveolar epithelium should be a key factor to be considered for the usage of ENaC agonists. The anticipated restore of alveolar fluid clearance may be seen
at the earlier stage of ALI and lung edema mainly
caused by injured pulmonary vasculature or post regeneration of alveolar epithelium by stem
cells/progenitors.

Conclusions and Perspectives
ENaC is involved in edema formation and kidney disorders. cGMP, either by serving as a ligand to
regulate cyclic nucleotide-gated ion channels or by
acting upstream of the PKG signaling systems, has a
role in the elimination of ENaC self-inhibition,
suggesting a novel mechanism for CPT-cGMP to
stimulate salt reabsorption. Compounds such as
specific PKGII activators and/or self-inhibition
inhibitors could be the basis for novel pharmaceutical
interventions for combating diseases associated with
impaired ENaC function. Future directions for study
include optimizing cGMP structure to potentiate its
efficacy in activating ENaC, evaluating its pharmaceutical relevance in preclinical and clinical models
with impaired ENaC activity, and confirming the
binding sites of cGMP in ENaC.
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